Company: CCM DUOPHARMA BIOTECH BHD
Stock Name: CCMDBIO
Amount: 0.145
Announcement Date: 16/03/2012
Ex Date: 06/06/2012
Dividend Detail:
EX-date: 06/06/2012
Entitlement date: 08/06/2012
Entitlement time: 04:00:00 PM
Entitlement subject: Final Dividend
Entitlement description: Final Dividend of 14.5 sen per ordinary share of RM0.50 each less 25% income tax.
Period of interest payment: to
Financial Year End: 31/12/2011
Share transfer book & register of members will be: to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no: Tricor Investor Services Sdn Bhd
Level 17, The Gardens North Tower
Mid Valley City, Lingkaran Syed Putra
59200 Kuala Lumpur
Telephone no: 03-2264 3883
Payment date: 29/06/2012
a. Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers: 08/06/2012
Entitlement indicator: Currency
Currency: Malaysian Ringgit (MYR)
Entitlement in Currency: 0.145
Remarks: The Final Dividend is subject to shareholders' approval at the forthcoming Annual General Meeting.
Stock Name: CCMDBIO
Amount: 0.145
Announcement Date: 16/03/2012
Ex Date: 06/06/2012
Dividend Detail:
EX-date: 06/06/2012
Entitlement date: 08/06/2012
Entitlement time: 04:00:00 PM
Entitlement subject: Final Dividend
Entitlement description: Final Dividend of 14.5 sen per ordinary share of RM0.50 each less 25% income tax.
Period of interest payment: to
Financial Year End: 31/12/2011
Share transfer book & register of members will be: to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no: Tricor Investor Services Sdn Bhd
Level 17, The Gardens North Tower
Mid Valley City, Lingkaran Syed Putra
59200 Kuala Lumpur
Telephone no: 03-2264 3883
Payment date: 29/06/2012
a. Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers: 08/06/2012
Entitlement indicator: Currency
Currency: Malaysian Ringgit (MYR)
Entitlement in Currency: 0.145
Remarks: The Final Dividend is subject to shareholders' approval at the forthcoming Annual General Meeting.
